MarleenMeyersMD

Oncology • New York, NY

Clinical Professor, Medicine, New York University School of Medicine

Join to view full profile

Dr. Meyers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyers' full profile

Already have an account?

Office
160 E 34th St
New York, NY 10016
Phone+1 212-731-5180

Education & Training

Einstein/ Cardozo MBE, Masters in Bioethics, 2019 - 2023
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
NYU Grossman School of MedicineResidency, Internal Medicine, 1979 - 1983
New York University School of MedicineClass of 1979

Certifications & Licensure

NY State Medical License 1981 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Exemestane and Cyclophosphamide for Metastatic Breast Cancer Start of enrollment: 2013 Sep 01
Completed
Phase 2

Publications & Presentations

PubMed

Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor
Journal of Neuro-Oncology. 2024-05-01
5 citations
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Kenneth Bernstein, Bernadine R Donahue
Neurosurgery. 2024-01-01
6 citations
Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis.
Matteo Malgaroli, Kristin L Szuhany, Gabriella Riley, Carly D Miron, Jae Hyung Park
Journal of Cancer Survivorship. 2023-10-01

Press Mentions

Risky Drinking Common in Cancer SurvivorsAugust 24th, 2023
Women Can Safely Interrupt Endocrine Tx to Pursue PregnancyDecember 12th, 2022
Breast Cancer Survivors Can Safely Pause Longer-Term Meds During PregnancyDecember 8th, 2022
Join now to see all